2015 American Transplant Congress Archives - Page 17 of 170

Paired Match Power and Challenges for O-Patients in Kidney Paired Donation

W. Liu, M. Melcher.
Paired-Donor Exchange Unrelated Living Donor Renal Transplantation With Two Separate Arterial Anastomoses to a Simultaneously Placed Vascular Prosthetic Interposition Graft in an Irradiated Field

D. Haakinson,¹ N. Katariya,¹ A. Singer,¹ A. Mathur,¹ R. Fowl,² S. Money,² W. Stone,² A. Moss,¹ K. Reddy.¹
Pancreas After Failed Islet Transplantation; a Successful Strategy to Maintain Insulin Independence

J. Gardner,¹ G. Roll,¹ S. Wisel,¹ J. Harbell,¹ B. Hynson,¹ D. Kaufman,² A. Posselt,¹ P. Stock.¹
Pancreas Transplant Sera Improves the Function and Proliferation of Endothelial Cells

J. Pollett, L. Margetich, N. Thai.
Pancreas Transplantation Immunosuppression Induction With Rabbit Antithymocyte Globulin +/- Rituximab and Early Steroid Withdrawal: Experience With >500 Recipients

J. Fridell,¹ R. Mangus,¹ J. Chen,² M. Mujtaba,³ T. Taber,³ M. Goble,¹ J. Powelson.¹
Pancreas-Derived Mesenchymal Stem Cells from Chronic Pancreatitis Patients Enhance Islet Graft Function

M. Lawrence,¹ F. Kunnathodi,¹ N. Borenstein-Auerbach,¹ G. Yoshimatsu,¹ M. Kanak,² R. Shahbazov,¹ M. Takita,¹ M. Levy,³ B. Naziruddin.³
Pancreatic Islet Survival Under Confinement

A. Rodriguez, S. Sigrist, E. Maillard.
Parameters of Machine Perfusion Evaluating Quality of Kidneys from DCD/ECD Donors

G. Chen, C. Wang, J. Qiu, M. Han, X. He, L. Chen.
Part II: Rates and Determinants of Progression for De Novo Donor-Specific Antibody Mediated Kidney Allograft Injury

C. Wiebe,^1,2 I. Gibson,³ D. Pochinco,² P. Birk,⁴ T. Blydt-Hansen,⁴ J. Ho,^1,5 M. Karpinski,¹ A. Goldberg,⁴ L. Storsley,¹ D. Rush,¹ P. Nickerson.^1,2,5
Passive Administration of Antibodies to Cardiac Myosin Immediately Following Syngenic Cardiac Transplantation Result in Rejection

M. Sharma, M. Gunasekaran, N. Benshoff, W. Liu, A. Gelman, T. Mohanakumar.
Patient and Graft Outcomes Following 3^rd, 4^th and 5^th Renal Transplants – A Single Centre Comparative Study

I. Loukopoulos, G. Rompianesi, P. Chandak, N. Mamode, F. Calder, N. Kessaris.
Patient and Process-Level Factors Associated With Kidney Transplant Readmissions

K. Covert, J. Fleming, C. Staino, J. Casale, K. Boyle, N. Pilch, H. Meadows, C. Mardis, J. McGillicuddy, C. Bratton, T. Srinivas, K. Chavin, P. Baliga, D. Taber.
Patient Outcomes After Listing for Kidney Alone Transplantation in Potential Recipients Aged Over 70 Years

D. Kanigicherla, M. Morton, I. Zia, J. Worthington, S. Sofia, T. Augustine, M. Picton.
Patient Self-Reported Adherence to and Perceptions Towards Immunosuppressive Medications at the Outpatient Renal Transplant Clinic at St. Joseph's Healthcare Hamilton (SJHH)

K. Kak,¹ C. Burger,¹ D. Treleaven,² C. Wallace.¹
Patients Referred to an OPO: Analysis of Potential for Additional DCD Donors

D. Bloomberg, J. Lewis, N. Benavides, M. James, H. Irving, A. Friedman.
Patients With Severe and Morbid Obesity Benefit from Deceased Donor Kidney Transplant

A. Nishio Lucar,¹ J. Ma,² G. Vranic,¹ D. Keith.¹
Patients With Spontaneous Bacterial Peritonitis (SBP) Experience Survival Benefit After Live Donor Liver Transplantation (LDLT)

M. Simpson, A. Qamar, F. Gordon, J. Pomposelli, M. Akoad, R. Jenkins, W. Lewis, A. Tien, E. Pomfret.
Pediatric Liver Transplantation for Metabolic Diseases: Analysis of Children's Hospital of Pittsburgh (CHP) and United Network for Organ Sharing (UNOS) Databases

A. Ganoza, B. Shneider, R. Sindhi, K. Soltys, G. Bond, G. Vockley, Q. Sun, G. Mazariegos.
Pediatric Liver Transplantation from Living Donors in Cali – Colombia

L. Caicedo, V. Botero, J. Villegas, O. Serrano, M. Duque, M. Valderrama, E. Manzi, M. Agudelo, G. Echeverri.
Pediatric Liver Transplantation: An Outcome Analysis of a 30-Year Single Center Experience

A. Weissenbacher,¹ C. Margreiter,¹ R. Oberhuber,¹ M. Maglione,¹ B. Cardini,¹ J. Grahammer,¹ T. Müller,² R. Margreiter,¹ S. Schneeberger.¹
Pediatric Living Donor Liver Transplantation at KFSH&RC – Implementation of the Laparoscopic Retrieval in a High Volume Center

M. Boehnert, M. Shagrani, T. Al Goufi, D. Broering.
Pediatrics & Donor Derived Disease Transmission: The US OPTN Experience

M. Green,¹ S. Taranto,² S. Covington,² M. Michaels,¹ C. Wolfe,³ D. Kaul.⁴
Perfusion Disturbances and Local Infarctions After Experimental Kidney Transplantation Corralte With the Duration of Cold Ischemia Time

S. Rong,¹ R. Chen,¹ M. Meier,⁴ B. Hensen,² H. Haller,¹ K. Hueper,² F. Gueler.¹
Perioperative Bacterial Colonization and Postoperative Urinary Tract Infection in Kidney Transplant Recipients

A. Han,¹ C. Choi,¹ S.-I. Min,¹ S.-K. Min,¹ S. Kim,² M. Park,³ J. Ha.¹
Peritransplant Costimulation Blockade and Rapamycin Therapy Induces Permanent Limb Allograft Survival

L. Wang, A. Samanta, J. Huang, T. Bhatti, Z. Wang, R. Han, L. Levin, M. Levine, W. Hancock.
Persistent Expansion of DX5- Memory NK Cells in the Liver After Intraportal Islet Transplantation

Y. Saeki, K. Ishiyama, N. Ishida, Y. Tanaka, H. Ohdan.
Pertubations in the Urinary Exosome in Transplant Rejection

T. Sigdel,¹ Y. Ng,¹ S. Lee,² C. Nicora,³ W.-J. Qian,³ D. Camp II,³ M. Sarwal.¹
Perturbation of Polyomavirus Nephropathy-Specific Gene Expression in Kidney Allografts

T. Sigdel,¹ O. Bestard,^1,2 N. Salomonis,³ S.-C. Hsieh,¹ M. Naesens,⁴ J. Torras,² T. Tran,¹ S. Roedder,¹ M. Sarwal.¹
Pharmacist-Led Renal-Sparing Conversion to Everolimus After Liver Transplantation

T. Horwedel,¹ L. Bowman,¹ W. Chapman,² J. Hagopian.¹
Pharmacoepidemiology of Cytomegalovirus Prophylaxis in a Large Multicenter Cohort of Kidney Transplant Recipients

C. Santos, D. Brennan, V. Fraser, M. Olsen.
Pharmacogenetic Variation in Renal Calcineurin Inhibitor (CNI) Metabolism and the Response of Allograft-Derived Proximal Tubule Cells

N. Knops,^1,2 L. van den Heuvel,² R. Masereeuw,³ H. de Loor,⁴ E. Levtchenko,^1,2 D. Kuypers.^5,4
Pharmacogenomic Predictors of Acute Rejection in Kidney Transplant Recipients Identified Using a DNA Biobank Linked to Electronic Medical Records

K. Birdwell,¹ D. Velez-Edwards,² G. Vranic,⁵ J. Denny,^1,3 L. Choi,⁴ T. Ikizler,¹ D. Haas.¹
Pharmacokinetics of Everolimus (EVL) in Elderly Recipients Under Low-Tacrolimus(TAC)/Everolimus in the First Year After Renal Transplantation. Data from the NEverOLd Trial

E. David-Neto,¹ P. Romano,² F. Agena,¹ P. Ebner,² A. Triboni,¹ F. Ramos,¹ N. Galante,¹ F. Lemos.¹
Pharmacokinetics of Mycophenolic Acid (MPA) in Elderly Compared to Young Recipients in the First Year After Renal Transplantation. Data from the NEverOLd Trial

P. Romano,¹ F. Agena,² P. Ebner,¹ A. Triboni,² F. Ramos,² N. Galante,² F. Lemos,² N. Sumita,¹ E. David-Neto.²
Pharmacokinetics of Tacrolimus (TAC) in Elderly Compared to Young Recipients in the First Year After Renal Transplantation. Data from the NEverOLd Trial

E. David-Neto,¹ P. Romano,² A. Triboni,¹ F. Agena,¹ P. Ebner,² F. Ramos,¹ N. Galante,¹ F. Lemos.¹
Phenotype Characterization, Migratory Pathways, Engraftment and Safety Evaluation of Human Cord Blood Derived Ex-Vivo Created Di- Chimeric Cells in NOD SCID Mouse Model: A Preliminary Study

J. Cwykiel,¹ A. Sklodowska,¹ W. Malewski,¹ M. Cyran,¹ H. Karagoz,¹ E. Bryndza Tfaily,¹ M. Askar,² M. Siemionow.¹
Phenotype of Renal Tubular Cell Death During Delayed Graft Function

S. Jain,¹ R. Plenter,¹ T. Nydam,¹ C. Ruller,¹ C. Edelstein,^1,2 A. Jani.^1,2
Phenotypic Personalized Medicine: Mechanism-Independent Convergence Into Target Serum Tacrolimus Levels for Optimized Liver Transplant Immunosuppression

A. Zarrinpar,¹ A. Silva,² D.-K. Lee,³ N. Datta,¹ C.-M. Ho,² D. Ho.³
PI3Kα and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune Polarization

E. Kefalogianni,¹ M. Mounayar,² B. Smith,² J. Azzi,² L. Chabtini,² P. Fiorina,² M. Kraus,³ R. Briddell,⁴ W. Fodor,⁵ A. Herrlich,¹ R. Abdi.²
Pilot Study on Safety and Feasibility of Complete Meal Replacement in Liver Transplant Recipients and Potential Donors

F. Bhatti,¹ M. Jesse,³ K. George,² J. Centala,⁴ J. Ehrman,⁵ A. Eshelman,³ M. Abouljoud,³ K. Brown.
Plasma 4β-Hydroxycholesterol Measurement as a Potential Biomarker for CYP3A5 Activity in Informing Tacrolimus Dosing

T. Elnahhas,^1,2 E. de Jonge,⁴ T. Lee,² B. van Zelst,⁴ J. Popoola,³ R. Ramkhelawon,³ R. van Schaik,⁴ A. Johnston,^1,2 I. MacPhee.³
Plasma Cell Infiltration: General Overview of Clinical and Pathological Correlations in Renal Transplantation

C. Nihei, F. Lemos, D. David, P. Souza, F. de Paula, W. Nahas, E. David-Neto.
Plasma Levels of Donor-Derived Cell-Free DNA Increase With Rejection and Often Decrease After Treatment in Organ Transplant Recipients

M. Grskovic,¹ J. Beausang,¹ D. Hiller,¹ R. Sit,¹ B. Christie,¹ J. Elechko,¹ R. Woodward,¹ J. Yee,¹ J. Kobashigawa.²
Plasmapharesis, Intravenous Immunoglobulin and Rituximab Successfully Treat Recurrent Progressive Familial Intrahepatic Cholestasis Type 2 (PFIC-2) After Liver Transplantation

H. Elsiesy,¹ F. Abaalkhail,¹ W. Alhamoudi,^1,2 H. Alhussaini,³ M. Alsebayel,¹ D. Broring,¹ M. Shagrani.¹
Plasmapheresis – A Previously Unrecognised Risk Factor for BK Viraemia

E. Olayos,¹ K. Barraclough,² R. Walker,³ R. Masterson,² H. Peter,² C. Solomon.⁴
Poor Renal Function and Increased Mortality in Elderly Recipients of Deceased Donor Kidneys from Elderly Donors

S. Berger,¹ H. Peters-Sengers,² M. Heemskerk,³ F. Bemelman,² J. Homan van der Heide.²
Portal Flow <1000 cc Is Not Associated With Early Graft Dysfunction in Orthotopic Liver Transplantation

M. Gastaca,¹ M. Prieto,¹ A. Matarranz,¹ A. Valdivieso,¹ P. Ruiz,¹ A. Ventoso,¹ I. Palomares,¹ L. Martinez-Indart,² J. Fernandez,³ J. Ortiz de Urbina.¹
Post Hoc Subgroup Analysis of ZEUS: Outcome on Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion from a Calcineurin Inhibitor to an Everolimus Based Regimen: 5 Year Follow-Up Data

F. Lehner,¹ K. Budde,¹ R. Wuethrich,² P. Reinke,¹ W. Arns,¹ A. Muehlfeld,¹ U. Eisenberger,¹ R. Stahl,¹ K. Heller,¹ O. Witzke,¹ B. Suwelack,¹ H. Wolters,¹ I. Hauser,¹ M. Porstner,³ C. Sommerer.¹
Post Transplant De Novo Donor Specific Antibodies Correlate With the Development of Bronchiolitis Obliterans Syndrome Following Pediatric Lung Transplantation

E. Melicoff, J. Maddox, M. Ebenbichler, J. Heinle, D. McKenzie, P. Jindra, G. Mallory, R. Kerman.
Post-Donation Outcomes in 46 Live Pancreas Donors

V. Kirchner, D. Sutherland, T. Dunn, E. Finger, T. Pruett, R. Kandaswamy.
Post-Kidney Allograft Nephrectomy Anti-HLA Immunization Is Not Due to a Release of Anti-HLA Antibodies from the Failed Kidney

D. Milongo,^1,3 N. Congy-Jolivet,^2,3,4 A. Del Bello,^1,3 F. Sallusto,⁵ C. Guilbeau-Frugier,⁶ L. Rostaing,^1,3 N. Kamar.^1,3
Post-Kidney Transplant Infections in Desensitized Patients Receiving Thymoglobulin or Daclizumab Induction: Results of a Randomized Clinical Trial

B. Orandi,¹ J. Locke,² E. Kraus,³ B. Lonze,¹ N. Desai,¹ N. Dagher,¹ N. Alachkar,³ C. Simpkins,⁴ F. Naqvi,³ D. Segev,¹ R. Montgomery,¹ R. Avery.³
Post-Liver Transplant Delirium Is Associated With Increased Mortality and Prolonged Length of Stay

N. Oliver,¹ S. Anders,¹ A. Freeman,¹ K. Fine,¹ A. Cohen,^1,2 G. Loss,^1,2 H. Bohorquez.^1,2
Post-Liver Transplant Metabolic Syndrome Increases the Risk of Recurrent Fibrosis in Patients With Hepatitis C

R. Sharma, M. Laurito, R. Brown, Jr., E. Verna.
Post-Transplant Changes in Serum Creatinine and Beta-2 Microglobulin Predict Acute Tubular Necrosis in the Early Post-Transplant Period

P. Liu,¹ A. Djamali,^1,2 D. Kaufman,^2,1 B. Astor.¹
Post-Transplant Lymphoproliferative Disorders Following Alemtuzumab Induction in Kidney Transplantation

H. Sawhney, R. Charif, J. Galliford, A. Mclean, D. Taube.
Post-Transplant Recurrence of Calcium Oxalate Crystals in Primary Hyperoxaluria Type 1 Detected by Surveillance Biopsies: Incidence, Risk Factors, and Effect on Graft Function

L. Cornell, N. Pamidi, R. Mehta, M. Stegall, E. Lorenz, J. Heimbach, D. Milliner.
Post-Transplantation Immunoadsorption Can Be Safely Withheld After ABO-Incompatible Kidney Transplantation

A. de Weerd,¹ M. van Agteren,¹ J. Ijzermans,² W. Weimar,¹ M. Betjes.¹
Potential Urine Protein Biomarkers for Kidney Transplantation Dysfunction Through Quantitative Proteomics

T. Sigdel,¹ N. Salomonis,² C. Nicora,³ J. He,³ W.-J. Qian,³ D. Camp,³ M. Sarwal.¹
Pre-Existing Coronary Artery Disease in Lung Transplantat Recipients: Does It Impact Outcomes?

S. Khandhar,¹ L. Tefera,² E. Volz,² F. Selzer,³ R. Kormos,² C. Bermudez.²
Pre-Liver Transplant Urinary Proteome Analysis Does Not Predict Development of Chronic Kidney Disease After Transplantation

D. Milongo,^1,3 J. Bascands,^2,3,4 L. Esposito,^1,3 L. Lavayssière,^1,3 A. Del Bello,^1,3 L. Rostaing,^1,3,5 J. Schanstra,^2,3,4 N. Kamar.^1,3,5
Pre-Operative Assessment of Body Composition in Adult Multivisceral Transplant Candidates

R. Cruz, H. Sogawa, G. Bond, K. Soltys, R. Sindhi, G. Mazariegos, A. Humar, A. DiMartini.
Pre-Transplant Angiotensin Receptor II Type 1 Antibodies (AT1R) and Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) as Predictors of Post Transpalnt FSGS Recurrence

A. Khalil, T. Tim, A. Sharfuddin, S. Doshi, M. Yaqub, D. Mishler, W. Goggins, M. Mujtaba.
Pre-Transplant Anti-LG3 Antibodies Enhance Allograft Dysfunction in Kidney Transplant Recipients With Delayed or Slow Graft Function

H. Cardinal, M. Hénault-Rondeau, S. Morissette, K. Hamelin, M.-J. Hébert.
Pre-Transplant Cardiac Troponin T (cTT) Is a Strong Predictor of Post Kidney Transplant Hospitalizations

H. Amer, P. Geerdes, T. Fettes, R. Walker, E. Lorenz, F. Cosio.
Pre-Transplant Desensitization Protocol and Cancer Risk in Kidney Transplantation

I. Revuelta,^1,2,3 R. Ferreira,¹ C. Canha,¹ P. Piselli,⁴ D. Verdirosi,⁴ V. Tubita,² E. De Sousa,¹ F. Diekmann,^1,2,3 M. Lozano,^2,5 J. Cid,⁵ E. Palou,⁶ J. Martorell,⁶ A. Alcaraz,⁷ D. Serraino,⁸ F. Oppenheimer,^1,2,3 J. Campistol.^1,2,3
Pre-Transplant Donor Specific Antibody With Negative Flow-Crossmatch Was Related to Higher Acute Rejection But Not to Poor Graft Survival

A. Guichard-Romero, L. Marino-Vazquez, M. Lopez, N. Castelan, A. De-Santiago, N. Uribe-Uribe, J. Alberu, L. Morales-Buenrostro.
Pre-Transplant Levels of TFH cell-Inducing Pro-Inflammatory Cytokines Correlate With DSA Formation After Kidney Transplantation

C. Macedo,¹ K. Hadi,¹ B. Elinoff,¹ M. Marrari,¹ A. Zeevi,¹ B. Ramaswami,¹ G. Chalasani,¹ A. Shields,² R. Alloway,³ E. Woodle,² F. Lakkis,¹ D. Metes.¹
Pre-Transplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Chronic Portal Vein Thrombosis

B. Thornburg, K. Desai, T. Baker, J. Fryer, M. Abecassis, J. Caicedo, L. Kulik, R. Salem.
Pre-Transplant Weight Change and New-Onset Diabetes After Kidney Transplantation

E. Huang, B. Abdalla, M. Andre, S. Bunnapradist.
Pre-Trasplant Perfusion With Mesenchymal Stromal Cells of Renal Graft Prevents Ischemia Injury Upregulating Gene Involved in Energy Saving

V. Corradetti,¹ S. Milanesi,¹ E. Pattonieri,¹ C. Rocca,¹ T. Valsania,¹ M. Gregorini,¹ L. De Cecco,² I. Benzoni,³ C. Bianco,³ M. Avanzini,⁴ M. Maestri,³ P. Esposito,¹ T. Rampino,¹ A. Dal Canton.
Precision Diagnosis in Kidney Transplantation

P. Kadota, D. Perkins.
Predicting and Preventing 30-Day Readmission Following Kidney Transplantation: A Single Center Study

R. Khaim,¹ V. Nair.^1,2
Predicting Graft Loss in a Population of Kidney Transplant Patients Diagnosed With ABMR/TG

J. Reeve,¹ P. Halloran.¹
Predicting Mental Health After Living Kidney Donation: The Importance of Donors' and Recipients' Medical Process

L. Timmerman,¹ M. Laging,¹ R. Timman,² W. Zuidema,¹ D. Beck,¹ J. IJzermans,³ M. Betjes,¹ J. Busschbach,² W. Weimar,¹ E. Massey.¹
Predicting Obstructive Coronary Artery Disease in Asymptomatic Renal Patients Undergoing Renal Transplantation

D.-A. Moutzouris, C. Baker, A. Malaweera, M. Willicombe, R. Corbett, N. Duncan, J. Galliford, A. McLean, D. Taube.
Predicting Renal Recovery After Liver Transplant With Severe Pretransplant Sub-Acute Kidney Injury: The Impact of Warm Ischemic Time

H. Laskey, T. Nydam, A. Wiseman, S. Biggins.
Predicting Survival of Deceased Donor Kidneys from Children Under Ten

W. Parker, J. Thistlethwaite, L. Ross.
Prediction of Acute Antibody Mediated Rejection in Antibody Incompatible Renal Transplantation Using Machine Learning for Wide Data

T. Shaikhina,¹ N. Khovanova,¹ S. Daga,^1,3 N. Krishnan,² D. Lowe,³ D. Mitchell,¹ D. Briggs,² R. Higgins.³
Prediction of Delayed Graft Function By Means of a Web-Based Calculator in Living Related Kidney Transplant: Mexican Single Center Experience

G. Martinez-Mier,¹ E. Soto-Miranda,¹ M. Mendez Lopez,¹ L. Budar Fernandez,¹ M. Trujillo-Martinez,² A. Uscanga-Montesano,² D. Avila y Falfan.²
Prediction of Long-Term Prognosis of the Kidney Transplantation Using Comorbidity Score

J. Park,¹ E. Bae,¹ S. Kim,² D. Kim,¹ C.-S. Lim,³ K. Joo,¹ Y. Kim,¹ J. Lee.³
Prediction of Post-Operative Length of Stay and Unplanned Reoperation in Patients Transplanted for Alcoholic Liver Disease: An Artificial Neural Network Approach

E. Wise, K. Williamson, K. Hocking.
Predictive Value of Cardiovascular Risk Assessment Tools in Kidney Transplantation

C. Dunn, A. Holtzman, M. Hung, S. Greenstein.
Predictive Value of Postoperative CRP and Procalctonin in Kidney Donors Experiencing Surgical Complications

Z. Ahmed, R. Tamburrini, J. Wright, N. Kessaris, N. Mamode.
Predictive Value of Regadenoson Scans After Heart Transplant

J. Kawano, M. Kittleson, J. Patel, B. Azarbal, F. Liou, S. Siddiqui, D. Wong, D. Chang, D. Ramzy, L. Czer, J. Kobashigawa.
Predictors of Deceased Donor Lung Utilization in the United States

L. Edwards,¹ L. Robbins Callahan,¹ J. Rogers,² K. Chan.³
Predictors of Time to Recurrence and Mortality Associated With Recurrent Hepatocellular Carcinoma After Liver Transplantation

A. Bodzin, D. Reino, K. Lunsford, M. Harlander-Locke, D. Markovich, A. Zarrinpar, F. Kaldas, D. Farmer, R. Busuttil, V. Agopian.
Preemptive Deceased Donor Transplant With Kidney Donor Profile Index Scores Greater Than 85 Not Associated With a Survival Benefit

D. Keith, A. Nishio Lucar, G. Vranic.
Preemptive Rituximab Therapy of Epstein-Barr Virus (EBV) Infection to Prevent Post-Transplant Lymphoproliferative Disease (PTLD) After Pediatric Solid Organ Transplantation (SOT)

Y. Ahn,¹ N.-J. Yi,² S. Min,² I.-S. Ha,¹ H. Cheong,¹ H. Kang.¹
Preemptive Therapy for Cytomegalovirus Disease in Liver Transplant Recipients-A Single Center Experience

N. Alvey,¹ J. Tieman,¹ A. Diamond,² A. Hodowanec,¹ D. Simon,¹ S. Fayek,¹ M. Hertl,¹ O. Olaitan,¹ E. Hollinger,¹ E. Chan.¹
Preferences for Policy Options for Deceased Organ Donation for Transplantation: A Discrete Choice Experiment

K. Howard,¹ S. Jan,² J. Rose,³ G. Wong,^1,4 J. Craig,^1,4 M. Irving,¹ A. Tong,^1,4 S. Chadban,^1,5 R. Allen,⁵ A. Cass.⁶
Preformed Anti-HLA DP Donor Specific Antibodies Are Clinically Significant in Renal Transplantation

V. Dibbur, M. Willicombe, P. Brookes, R. Sergeant, A. Wardle, D. Taube.
Preformed IgA Antibodies to B2-Glycoprotein Is an Indepedent Risk Factor for Graft Thrombosis and Early Graft Loss After Renal Transplantation

J. Morales,¹ M. Serrano,³ J. Martinez,² D. Perez,² M. Sevilla,² A. Amdres,³ E. Gonzalez,³ E. Paz-Artal,² A. Serrano.²
Pregnancy After Renal Transplantation: Unfavorable Outcomes in Sensitized Patients

M. Ajaimy, M. Lubetzky, L. Kamal, G. De Bocardo, E. Akalin.
Pregnancy Outcomes in Female Kidney Recipients Who Conceived Before Age 20

L. Coscia,¹ D. Armenti,¹ S. Constantinescu,² M. Moritz.¹
Pregnancy Outcomes in Female Kidney Transplant Recipients: Does Ethnicity Have an Influence?

S. Constantinescu,^1,2 L. Coscia,² D. Armenti,² P. Axelrod,¹ M. Ghanta,¹ S. Rao,¹ M. Moritz.^2,3
Pregnancy Outcomes in Kidney Recipients With Longer Transplant to Conception Intervals

S. Constantinescu,^1,2 L. Coscia,² D. Armenti,² P. Axelrod,¹ M. Ghanta,¹ S. Rao,¹ M. Moritz.^2,3
Pregnancy Outcomes in Solid Organ Transplant Recipients With Exposure to Sirolimus Without Mycophenolate

N. Sifontis,¹ L. Coscia,² D. Armenti,² S. Constantinescu,^2,3 M. Moritz.^2,4
Prehypertension and Abnormal Fasting Glucose Are the Main Factors Associated With Progressive Deterioration of Renal Function in Kidney Donors

J. Arreola-Guerra,¹ M. Arvizu-Hernandez,² R. Correa-Rotter,² L. Morales-Buenrostro,² J. Alberu.¹
Preliminary Results of a Novel Induction Regimen Using Anti-Thymocyte Globulin (Rabbit) (rATG) Plus Basiliximab in a Pediatric Patient Population Undergoing Kidney Transplantation

D. Halleran,¹ S. Schurman, T. Welch, V. Whittaker.
Presence of Donor Leukocytes and Donor MHC-Cross-Dressed Recipient Cells and Its Relationship to Direct T Cell Alloresponses After Allotransplantation

J. Marino,¹ P. Crosby Bertorini,¹ M. Uehara,² J. Paster,¹ S. Mordecai,³ W.-H. Liu,¹ L. Liu,¹ R. Abdi,² G. Tocco,¹ J. Kim,¹ J. Markmann,¹ G. Benichou.¹
Preservation Solution Impacts Short- and Long-Term Survival in Orthotopic Heart Transplant Recipients

C. Lewis,¹ S. Jayarajan,¹ S. Taghavi,¹ S. Kadakia,¹ V. Ambur,¹ A. Shiose,³ G. Wheatley,³ L. Kaiser,² T. Guy,³ Y. Toyoda.³
Preserved Kidney Volume in Living Kidney Donors: Correlation With 2 Year Renal Function Using CKD-EPI Equation to Predict Remaining GFR

A. Khalil,¹ M. Yaqub,¹ T. Taber,¹ J. Powelson,¹ C. Sundaram,¹ W. Goggins,¹ D. Mishler,¹ M. Mujtaba,¹ A. Diez,² A. Sharfuddin.¹
Pretransplant Antibodies Against Angiotensin II Type 1 Receptor in Renal Transplantation: Preliminary Data from the KNOW-KT Study

K. Huh,¹ J. Lee,¹ Y. Park,² Y. Kim,¹ C. Ahn.³
Pretransplant Assessment of Vascular Calcification as a Risk Factor of Mortality, Graft Loss, and Cardiovascular Events in Renal Transplant Recipients

P. Munguia, R. Caramelo, M. Rubio, L. Sahdalá, L. Arnaudas, J. Paul, á. Blasco, L. Lou, M. Aladren, A. Sanjuan, A. Gutierrez-Dalmau.
Pretransplant Elevated Plasma Fibrinogen Level Is Associated With Tumor Recurrence and Poor Prognosis in Hepatocellular Carcinoma Patients After Liver Transplantation

G.-Y. Wang, Y. Yang, H. Li, S.-H. Yi, G.-H. Chen.
Pretransplant Hepatitis B Viral Infection Increased Risk of Death After Kidney Transplantation

J. Lee,¹ J.-H. Cho,² J. An,³ C.-D. Kim,² C. Ahn,⁴ I. Jung,³ D. Han, C. Lim,³ Y. Kim,⁴ Y. Kim, J. Lee.³
Pretransplant Panniculectomy in Patients Previously Denied Access to Renal Transplantation: Addressing Disparities for Candidates With a High-Risk Abdominal Panniculus After Weight Loss

C. Troppmann,¹ C. Bailey,² J. Kuo,² C. Santhanakrishnan,¹ R. Perez,¹ M. Wong.²
Prevalence and Clinical Outcomes Associated With Vancomycin-Resistant Enterococcal Colonization Or Infection After Small Intestinal Transplantation

N. Shah,¹ L. Nabha,² R. Teran,³ C. Matsumoto,⁴ R. Farney,⁵ P. Kumar,⁶ J. Timpone.⁷
Prevalence and Outcomes of Heart Transplantation in Children With Intellectual Disability

A. Wightman,¹ H. Bartlett,¹ Q. Zhao,² J. Smith.³
Prevalence, Risk Factors, and Clinical Management of Chronic Renal Dysfunction in Heart Transplant Recipients

K. Xhima, O. Famure, Y. Li, J. Kim.
Preventing Cytomegalovirus Infection in Intermediate-High Risk Liver Transplant Recipients: Acyclovir Vs Valganciclovir

S. Dulanya, A. Anamisis, D. Tsapepas.
Primary and Secondary Vaccine Responses in a Non-Human Primate Model of Cardiac Allotransplantation

S. Dahi,¹ E. Kang,¹ T. Zhang,¹ B. Vanhove,² A. Azimzadeh,¹ R. Pierson III.¹
Pro-Inflammatory Actions of New Non-HLA Antibodies Targeting Protease-Activated Receptor (PAR-1)

R. Catar,¹ C. Luecht,¹ M. Simon,¹ A. Philippe,¹ A. Kusch,¹ M. Szczepek,² P. Hildebrand,² P. Scheerer,² D. Dragun.¹
Process Deviation Tracking and Analysis in an Organ Procurement Organization

B. Schleich,¹ S. Yoon,¹ M. Khasawneh,¹ K. Srihari,¹ H. Irving,² A. Friedman.
Profound Effect of HDAC2 Deletion on Renal Ischemia-Reperfusion Injury Is Intrinsic to the Kidney and Includes Protection Against Cold Ischemia

D. Aufhauser, Jr.,¹ Z. Wang,¹ S. Cheraghlou,¹ T. Bhatti,² W. Hancock,^2,3 M. Levine.^1,4
Prognostic Relevance of Rejection Episodes Detected Within the First 3 Weeks After Kidney Transplantation

V. Arelin,¹ H. Schrem,² F. Lehner,² W. Gwinner,¹ H. Haller,¹ M. Schiffer.¹
Program-Effect Attenuation With Time Posttransplant

N. Salkowski,¹ L. Hunsicker,^1,2 J. Snyder,¹ B. Kasiske.^1,3
Progression of Coronary Artery Disease in High-Risk Patients Undergoing Renal Transplantation

R. Corbett, N. Kumar, C. Baker, D. Moutzouris, M. Willicombe, J. Galliford, A. McLean, N. Duncan, D. Taube.
Propensity Score-Weighted Analysis of Induction Therapies in Live Donor Kidney Transplantation in Modern Immunosuppression Era

B. Tanriover,¹ S. Zhang,² M. MacConmara.³
Prophylaxis of Post-Renal Transplant Urinary Tract Infection With Fosfomycin Trometamol. A Controlled, Randomized Clinical Trial. (Intermediate Analysis)

J. Arreola-Guerra,¹ L. Morales-Buenrostro,³ M. Arvizu-Hernandez,³ E. Mancilla-Urrea,² P. Maria,² M. Vilatoba-Chapa,¹ J. Alberu,¹ J. Sifuentes-Osornio.¹
Prospective Measurement of Plasma Neutrophil Gelatinase-Associated Lipoprotein in Living Kidney Donors

Y. Yoon,¹ K. Choi,² D. Joo,³ K. Huh,³ M. Kim,³ S. Kim,³ Y. Kim,³ S. Yang,² W. Han.¹
Prospective Study of a Steroid Free, Low Dose Tacrolimus and Everolimus Combination Regimen in Kidney Transplant

A. Shetty,¹ J. Leventhal,¹ O. Traitanon,¹ A. Alvarado,¹ V. Mas,² J. Mathew,¹ E. Tantisattamo,¹ L. Gallon.¹
Prospective, 6 Month, Open Label, Conversion Study from Mycophenolate Mofetyl to Mycophenolic Acid Evaluating the Severity of Gastro-Intestinal Symptoms and Mycophenolic Acid Urinary Metabolite as a Surrogate Marker of Plasmatic Area Under the Curve

D. Tran,¹ A. Boucher,¹ L. Senécal,¹ V. Pichette,¹ F. Leblond,² S. Collette.¹
Prospects of Differentiating T-Cell Mediated Rejection (TCMR) from BK Virus Nephropathy (BKVN) Using Next Generation Sequencing (NGS) of the T-Cell Receptor (TCR)

G. Zeng, Y. Huang, P. Randhawa.
Proteasome Activation During Renal Cold Storage and Transplantation: A Novel Pathway for Mitochondrial Destruction?

N. Parajuli, L. MacMillan-Crow.
Proteasome Inhibition by Bortezomib Prevents Early Graft Failure After Pancreatic Islet Transplantation

H. Ono,¹ Y. Asahi,¹ T. Yoshida,¹ Y. Koshizuka,¹ M. Watanabe,¹ U. Tomaru,² S. Emoto,¹ M. Fukai,³ A. Taketomi,¹ S. Todo,⁴ K. Yamashita.³
Protecting Older Patients from Dialysis: The Survival Benefit of Preemptive Transplant With High KDPI Allografts

C. Jay,¹ K. Washburn,¹ P. Dean,² R. Helmick,² M. Stegall.²
Proteinuria as Non-Invasive Marker for Renal Allograft Histology and Survival: A Population-Based Study

M. Naesens, E. Lerut, M.-P. Emonds, D. Kuypers.
Proteomic Study Identified a Distinct Panel of Protein Expression in the ATP-Competitive MTOR Kinase Inhibitor Conditioned Dendritic Cells Compared to Rapamycin

T. Ma,¹ Y. Pei,¹ Y. Han,² R. Tao.¹
Protocol Donor Specific Antibody Monitoring After Kidney Transplantation: What Is the Utility?

C. Staino, N. Pilch, O. Moussa, K. Boyle, J. Casale, K. Covert, J. Fleming, D. Taber, H. Meadows, C. Mardis, K. Chavin, S. Nadig, J. McGillicuddy, C. Bratton, T. Srinivas, P. Baliga.
Proximal Tubular Dysfunction Is Common After the First Year of Kidney Transplantation

G. Ensergueix,¹ J. Allard,¹ F. Saint-Marcoux,² B. Marin,³ S. Bodeau,² J.-C. Aldigier,¹ P. Marquet,² M. Essig.¹
Psychiatric Recommendations for Patients Pursing Kidney Transplantation

M. Jesse, A. Eshelman, T. Rosetti, M. Abouljoud, J. Denny, A. Patel, D. Kim.
Psychological Benefit After Living Kidney Donation: Is It a Myth?

H. Maple, N. Mamode.
Pubertal Development in Pediatric Kidney Transplant Patients Receiving Everolimus Or Conventional Immunosuppression

L. Pape,¹ T. Ahlenstiel-Grunow,¹ A. Zapf,² M. Mynarek,³ J. Förster.¹
Pyridoxine Deficiency After Solid Organ Transplant

S. Van Arsdale,¹ S. Yost,² M. Meer,¹ S. Schoentag,¹ P. Kadambi,³ S. Habib.³